| Dr Charles L Meyers, MD | |
|
501 Gordon Dr, Exton, PA 19341-1252 | |
| (610) 594-6660 | |
| (610) 594-6810 |
| Full Name | Dr Charles L Meyers |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 23 Years |
| Location | 501 Gordon Dr, Exton, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225097769 | NPI | - | NPPES |
| 3828750 | Other | PA | AETNA HEALTH PLANS |
| 2405639000 | Other | PA | INDEPENDENCE BLUE CROSS |
| 1738866 | Other | PA | PENNSYLVANIA BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD425728 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pennsylvania Centre For Dermatology, Llc | 4183603335 | 35 |
News Archive
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
In a study of patients with chronic kidney disease, persistent substance use-;especially of hard illicit drugs-;was linked with higher risks of CKD progression and early death. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
Chromatrap®, a business unit of Porvair Sciences, has produced a new 10-page brochure that provides an informative introduction to chromatin immunoprecipitation (ChIP) technology and a detailed comparison of traditional bead based and Chromatrap® solid state ChIP technologies.
Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths. New nanotechnology developed at Case Western Reserve University detects these metastases in mouse models of breast cancer far earlier than current methods, a step toward earlier, life-saving diagnosis and treatment.
New research involving medical experts at The University of Nottingham has found that steroid tablets do not reduce the symptoms of virus-induced wheezing in pre-school children.
› Verified 1 days ago
| Entity Name | Bryn Mawr Medical Specialists Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841226099 PECOS PAC ID: 4183610934 Enrollment ID: O20040426000467 |
News Archive
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
In a study of patients with chronic kidney disease, persistent substance use-;especially of hard illicit drugs-;was linked with higher risks of CKD progression and early death. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
Chromatrap®, a business unit of Porvair Sciences, has produced a new 10-page brochure that provides an informative introduction to chromatin immunoprecipitation (ChIP) technology and a detailed comparison of traditional bead based and Chromatrap® solid state ChIP technologies.
Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths. New nanotechnology developed at Case Western Reserve University detects these metastases in mouse models of breast cancer far earlier than current methods, a step toward earlier, life-saving diagnosis and treatment.
New research involving medical experts at The University of Nottingham has found that steroid tablets do not reduce the symptoms of virus-induced wheezing in pre-school children.
› Verified 1 days ago
| Entity Name | Pennsylvania Centre For Dermatology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861501801 PECOS PAC ID: 4183603335 Enrollment ID: O20040720000493 |
News Archive
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
In a study of patients with chronic kidney disease, persistent substance use-;especially of hard illicit drugs-;was linked with higher risks of CKD progression and early death. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
Chromatrap®, a business unit of Porvair Sciences, has produced a new 10-page brochure that provides an informative introduction to chromatin immunoprecipitation (ChIP) technology and a detailed comparison of traditional bead based and Chromatrap® solid state ChIP technologies.
Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths. New nanotechnology developed at Case Western Reserve University detects these metastases in mouse models of breast cancer far earlier than current methods, a step toward earlier, life-saving diagnosis and treatment.
New research involving medical experts at The University of Nottingham has found that steroid tablets do not reduce the symptoms of virus-induced wheezing in pre-school children.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles L Meyers, MD 501 Gordon Dr, Exton, PA 19341-1252 Ph: (610) 594-6660 | Dr Charles L Meyers, MD 501 Gordon Dr, Exton, PA 19341-1252 Ph: (610) 594-6660 |
News Archive
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
In a study of patients with chronic kidney disease, persistent substance use-;especially of hard illicit drugs-;was linked with higher risks of CKD progression and early death. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology.
Chromatrap®, a business unit of Porvair Sciences, has produced a new 10-page brochure that provides an informative introduction to chromatin immunoprecipitation (ChIP) technology and a detailed comparison of traditional bead based and Chromatrap® solid state ChIP technologies.
Malignant cells that leave a primary tumor, travel the bloodstream and grow out of control in new locations cause the vast majority of cancer deaths. New nanotechnology developed at Case Western Reserve University detects these metastases in mouse models of breast cancer far earlier than current methods, a step toward earlier, life-saving diagnosis and treatment.
New research involving medical experts at The University of Nottingham has found that steroid tablets do not reduce the symptoms of virus-induced wheezing in pre-school children.
› Verified 1 days ago
Dr. Michael S Lehrer, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 501 Gordon Dr, Exton, PA 19341 Phone: 610-594-6660 Fax: 610-594-6810 | |
Dr. Scott Lawrence Gottlieb, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 501 Gordon Dr, Exton, PA 19341 Phone: 610-594-6660 Fax: 610-594-6810 | |
Hannah Yaqian Liu, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 80 W Welsh Pool Rd Ste 103n, Exton, PA 19341 Phone: 610-634-8500 Fax: 610-982-1555 | |
Dr. Daniel Dvorkin, MD Dermatology Medicare: Medicare Enrolled Practice Location: 319 N Pottstown Pike, Suite 102, Exton, PA 19341 Phone: 215-305-8834 Fax: 610-363-2026 | |
Dr. Aerlyn G Dawn, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 501 Gordon Dr, Exton, PA 19341 Phone: 610-594-6660 Fax: 610-594-6810 |